Related Experiment Video
Updated: May 15, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR
Baojian Wu1, Sha Li, Dong Dong
1Division of Pharmaceutics, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou, Guangdong 510632, China. bj.wu@hotmail.com
Abstract:
The nuclear receptors constitutive androstane receptor (CAR), pregnane X receptor (PXR) and vitamin D receptor (VDR) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters. 3D structures for the ligand-binding domain (LBD) of these receptors are abundantly available, providing valuable insights into the ligand-binding specificity as well as the activation mechanisms. The ligand-binding site of PXR is large and flexible, whereas those of CAR and VDR are compact and rigid, respectively. In general, the ligand profiles of the receptors are in agreement with the LBD structures. The crystal structures have greatly helped us to understand the promiscuity and/or specificity of CAR, PXR and VDR.
Insights
Constitutive androstane receptor (CAR), pregnane X receptor (PXR), and vitamin D receptor (VDR) are key human proteins. Their 3D structures reveal ligand-binding specificities and activation mechanisms, explaining receptor promiscuity and specificity.
Area of Science:
- Molecular Biology
- Structural Biology
- Pharmacology
Background:
- Nuclear receptors like CAR, PXR, and VDR regulate critical human genes, including those for metabolic enzymes and transporters.
- The 3D structures of their ligand-binding domains (LBDs) are crucial for understanding how they bind to various molecules and become activated.
Purpose of the Study:
- To analyze the 3D structures of the ligand-binding domains (LBDs) of CAR, PXR, and VDR.
- To correlate structural features with known ligand-binding profiles and activation mechanisms.
- To elucidate the molecular basis for the specificity and promiscuity of these nuclear receptors.
Main Methods:
- Analysis of existing 3D crystal structures of the ligand-binding domains (LBDs) of CAR, PXR, and VDR.
- Comparison of the structural characteristics of the ligand-binding sites.
- Correlation of structural data with published ligand-binding data for each receptor.
Main Results:
- The ligand-binding site of PXR is characterized as large and flexible.
- The ligand-binding sites of CAR and VDR are described as compact and rigid, respectively.
- Observed ligand profiles for CAR, PXR, and VDR generally align with their respective LBD structural features.
Conclusions:
- The 3D structures of CAR, PXR, and VDR LBDs provide significant insights into their ligand-binding specificities.
- Structural variations in the ligand-binding sites explain the differential promiscuity and specificity of these receptors.
- Crystal structures are invaluable tools for understanding nuclear receptor function and drug interactions.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Drug-Receptor Bonds
In...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Signal Transduction: Overview
Typically, signal transduction involves three...
